靶分子疗法在脉络膜新生血管治疗中的研究
被引量：2
摘要
脉络膜新生血管的发生与新生血管抑制因子和生长因子的失衡有关,近年开展的靶分子疗法是一种新的独特的治疗脉络膜新生血管的方法,包括抗血管内皮生长因子、抗脉络膜新生血管内皮细胞的单克隆抗体、组织蛋白酶抑制剂和色素上皮源性因子等。本文对这些研究的进展进行综述。
出处
《国外医学（眼科学分册）》
2005年第2期106-109,共4页
Foreign Medical Sciences(Section of Ophthalmology )
参考文献25
-
1Singerman LJ, Eyetech Study Group. Anti-VEGF therapy for subfoveal choroidal neovascularization to age-related macular degeneration: Phase IB results. Association for Research in Vision and Ophthalmology Annual Meeting, 2002, Abstract: 2908.
-
2The Eyetech Study Group. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration. Retina, 2002,22:143-152.
-
3The Eyetech Study Group. Anti-VEGF therapy for subfoveal choroidal neovascularization to age-related macular degeneration: phase Ⅱ study results. Ophthalmology, 2003,110:979-986.
-
4Kong HL, Hecht D, Song W, et al. Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor. Hum Gene Ther, 1998, 9:823-833.
-
5Demetriades AM, Gehlbach PL, Yamamoto S, et al. Periocular injection of an adenoviral vector expressing the extracellular portion of vascular endothelial growth factor receptor-1 (Ads-flt. 10 ) inhibits choroidal neovascularization. Association for Research in Vision and Ophthalmology Annual Meeting, 2002, Abstract: 3916.
-
6Honda M, Sakamoto T, Ishibashi T, et al. Experimental subretinal neovascularization is inhibited by adenovirusmediated soluble VEGF/flt-1 receptor gene transfection:a role of VEGF and possible treatment for SRN in age-related macular degeneration. Gene Ther,2000,7:978-985.
-
7Lai CM, Brankov M, Zaknich T, et al. Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization. Hum Gene Ther, 2001,12:1299-1310.
-
8Lai YK, Shen WY, Brankov M, et al. Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy. Gene Ther,2002,9:804-813.
-
9Bainbridge JW, Mistry A, De Alwis M, et al. Inhibition of retinal neovascularization by gene transfer of soluble VEGF receptor sFlt-1.Gene Ther, 2002,9:320-326.
-
10Krzystolik MG, Afshari MA, Adamis AP, et al. Prevention of experimental choroidal neovaseularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol,2002,120:338-346.
同被引文献32
-
1乔岗,周希瑗.基因治疗脉络膜新生血管的进展[J].国外医学（眼科学分册）,2004,28(3):211-214. 被引量：3
-
2王雨生,朱洁.脉络膜新生血管性疾病的治疗现状[J].第四军医大学学报,2006,27(6):481-483. 被引量：12
-
3王玲,卢清君,王宁利,王津津.人眼脉络膜黑色素细胞的培养与鉴定[J].眼科研究,2006,24(3):248-251. 被引量：5
-
4Steen B,Sejersen S,Berglin L,et al.Matrix metalloproteinases and metalloproteinase inhibitor in choroidal neovascularization membranes[J].Invest Ophthalmol Vis Sci,1998,39:2194-2200
-
5Hoffmann S,He S,Jin ML,et al.Carboxyamido-triazole modulates retinal pigment epithelial and choroidalendothelial cell attachment,migration,proliferation,and MMP-2 secretion of choroidal endothelial cells[J].Curr Eye Res,2005,30:103-113
-
6Hu DN,McCormick SA,Ritch R,et al.Studies of human uveal melanocytes in vitro:isolation,purification and cultivation of human uveal melanocytes[J].Invest Ophthalmol Vis Sci,1993,34:2210-2219
-
7Hu DN,McCormick SA,Ritch R.Studies of human uveal melanocytes in vitro:growth regulation of cultured human uveal melanocytes[J].Invest Ophthalmol Vis Sci,1993,34:2220-2227
-
8Frank RN.Growth factors in age-related macular degeneration:pathogenic and therapeutic implications[J].Ophthalmic Res,1997,29:341-353
-
9Kimura H,Sakamoto T,Hinton DR,et al.A new model of subretinal neovascularization in the rabbit[J].Invest Ophthalmol Vis Sci,1995,36:2110 -2119
-
10Alexander JP,Bradley JM,Gabourel JD,et al.Expression of matrix metalloproteinases and inhibitor by human retinal pigment epithelium[J].Invest Ophthalmol Vis Sci,1990,31:2520-2528
二级引证文献3
-
1王宁利,杨迪亚.同仁医院眼科近年来青光眼基础研究概述[J].眼科,2009,18(1):17-21. 被引量：1
-
2孙晓雯,黄旭东,王剑锋,姜雅琴.碱性成纤维细胞生长因子在眼后节组织损伤中的作用[J].中国实用眼科杂志,2010,28(7):699-702. 被引量：5
-
3杨晶晶,何湘珍.基质金属蛋白酶与眼科疾病的研究进展[J].国际眼科杂志,2011,11(7):1185-1187. 被引量：2
-
1王倩,姚定康.原发性胆汁性肝硬化的药物治疗研究进展[J].临床肝胆病杂志,2014,30(5):462-465. 被引量：4
-
2李亚永,江新利,马会杰,刘岩.色素上皮衍生因子抑制糖尿病视网膜血管病变的研究新进展[J].河北医科大学学报,2014,35(11):1353-1357. 被引量：5
-
3李维纳,李瑞庄,谭思敏,黎宗汉,柯毅.抑制角膜新生血管的治疗进展[J].广东医学院学报,2011,29(5):552-554.
-
4李筱荣,刘巨平,李艳,袁佳琴.链脲佐菌素诱导的糖尿病大鼠视网膜VEGF、PEDF的动态表达[J].眼外伤职业眼病杂志,2007,29(8):654-655.
-
5韩根生.血清转化生长因子β1和内皮抑素水平与增殖性糖尿病视网膜病变的关系[J].医药论坛杂志,2016,37(11):51-52.
-
6顾俊,王长谦.碱性成纤维细胞生长因子与冠心病[J].中国循环杂志,2005,20(1):76-78.
-
7宋晓莲,崔元孝.色素上皮源性因子在心脑血管疾病检测中的意义[J].医学与哲学（B）,2012,33(8):28-29. 被引量：1
-
8路建军,张勇涛,倪梅,吕慧霞.细胞色素上皮源性因子对巨噬细胞表面CD36蛋白表达的影响[J].山东医药,2017,57(1):4-6. 被引量：2
-
9董为人,田雪梅.阻塞性血管疾病分子治疗新概念[J].医学综述,1997,3(12):547-551.
-
10顾起宏,朱美玲.光动力疗法在脉络膜新生血管治疗中的应用[J].中国眼耳鼻喉科杂志,2004,4(2):127-129.
